GSK plc ADR Stock
Price
Target price
€36.20
€36.20
2.840%
-
2.840%
€49.33
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
GSK plc ADR Stock
GSK plc ADR gained 2.840% today.
Our community is currently high on GSK plc ADR with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 49 € shows a positive potential of 35.36% compared to the current price of 36.2 € for GSK plc ADR.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for GSK plc ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of GSK plc ADR in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of GSK plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| GSK plc ADR | 2.840% | 6.471% | 2.841% | -3.723% | 10.366% | -27.600% | -22.979% |
| Astrazeneca ADR | -0.790% | 0.794% | -1.550% | -12.414% | -0.781% | 3.420% | - |
| Bayer AG ADR | -4.650% | 2.381% | 8.403% | -6.522% | 30.040% | -60.429% | -59.938% |
| Roche Holding AG ADR | -0.190% | 1.978% | -2.215% | 19.846% | 6.786% | -8.368% | -9.086% |
Comments
Hey there! I've been keeping an eye on GSK plc ADR, and I gotta say, it's looking pretty interesting right now. With RFK Jr. potentially heading up HHS, we're in for a wild ride in the biotech world. It's like we're about to shake up a snow globe and see where all the flakes land, you know? While this might create some short-term turbulence, I think GSK's solid fundamentals and diverse portfolio could help it weather the storm and even come out stronger. It's like they're a sturdy ship in choppy waters - they might get rocked a bit, but they're built to last. Plus, at the current price, it feels like we're getting a decent deal. What do you think? Could this be a chance to grab a quality pharma stock at a discount before it potentially climbs higher?
Show more
GSK plc (NYSE: GSK) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for GSK provided by MarketBeat